Helius Medical Technologies (NASDAQ: HSDT) has taken its first major step into digital assets, announcing the purchase of 760,190 SOL tokens. The purchase done at an average cost of $231 per token is part of the company’s newly launched solana-focused treasury strategy.

In addition to its current holdings, Helius said it has over $335 million in cash reserves for further SOL purchases. By prioritizing solana, the company aims to become a long-term institutional holder of the network’s native token.

Helius emphasized that its strategy supports the growth and security of tokenized networks, positioning the firm as both a treasury player in digital assets and a medical technology company.

“It has been gratifying to receive shows of support from multiple stakeholders across the Solana ecosystem, including staking providers, defi protocols, and others. We take our responsibility to maximize shareholder value seriously and are eager to execute against our plan,” said Joseph Chee, Executive Chairman of Helius Medical.

The move places HSDT among a growing list of firms integrating blockchain exposure into their balance sheets, while reinforcing confidence in solana’s role as a leading smart contract network.

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。